These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464 [TBL] [Abstract][Full Text] [Related]
4. Cyclic Stretch and Perfusion Bioreactor for Conditioning Large Diameter Engineered Tissue Tubes. Schmidt JB; Tranquillo RT Ann Biomed Eng; 2016 May; 44(5):1785-97. PubMed ID: 26307332 [TBL] [Abstract][Full Text] [Related]
8. Design of a Mechanobioreactor to Apply Anisotropic, Biaxial Strain to Large Thin Biomaterials for Tissue Engineered Heart Valve Applications. Wong E; Parvin Nejad S; D'Costa KA; Machado Siqueira N; Lecce M; Santerre JP; Simmons CA Ann Biomed Eng; 2022 Sep; 50(9):1073-1089. PubMed ID: 35622208 [TBL] [Abstract][Full Text] [Related]
9. A novel flex-stretch-flow bioreactor for the study of engineered heart valve tissue mechanobiology. Engelmayr GC; Soletti L; Vigmostad SC; Budilarto SG; Federspiel WJ; Chandran KB; Vorp DA; Sacks MS Ann Biomed Eng; 2008 May; 36(5):700-12. PubMed ID: 18253834 [TBL] [Abstract][Full Text] [Related]
10. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156 [TBL] [Abstract][Full Text] [Related]
11. Non-physiologic Bioreactor Processing Conditions for Heart Valve Tissue Engineering. VeDepo MC; Buse EE; Paul A; Converse GL; Hopkins RA Cardiovasc Eng Technol; 2019 Dec; 10(4):628-637. PubMed ID: 31650518 [TBL] [Abstract][Full Text] [Related]
12. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Syedain ZH; Meier LA; Bjork JW; Lee A; Tranquillo RT Biomaterials; 2011 Jan; 32(3):714-22. PubMed ID: 20934214 [TBL] [Abstract][Full Text] [Related]
13. Decellularized tissue-engineered heart valve leaflets with recellularization potential. Syedain ZH; Bradee AR; Kren S; Taylor DA; Tranquillo RT Tissue Eng Part A; 2013 Mar; 19(5-6):759-69. PubMed ID: 23088577 [TBL] [Abstract][Full Text] [Related]
14. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792 [TBL] [Abstract][Full Text] [Related]
15. Tissue-engineered fibrin-based heart valve with a tubular leaflet design. Weber M; Heta E; Moreira R; Gesche VN; Schermer T; Frese J; Jockenhoevel S; Mela P Tissue Eng Part C Methods; 2014 Apr; 20(4):265-75. PubMed ID: 23829551 [TBL] [Abstract][Full Text] [Related]